에 대한 최신 뉴스 Align Technology (NASDAQ:ALGN) 주식

Align Technology

Align Tech

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Why It Matters

News

Price Target

Markets

Analyst Ratings

Trading Ideas

ALGN

GOOGL

INCY

LYFT

PENN

TSLA

화요일(18일) 월가의 상위 애널리스트들이 아래 종목에 대한 전망을 변경했다.  모든 애널리스트의 등급 변경 사항은 애널리스트 등급 페이지에서 확인할 수 있다. 아메리칸 익스프레스, 센티넬원, 펜 엔터테인먼트, GE 버노바, 얼라인, 씨게이트, 리프트, 테슬라, 인사이트, 알파벳

월가 상위 애널리스트 의견 변동: 테슬라 목표주가 320달러?

Businessman.Markets.Shutterstock

Politics

NVDA

PYPL

VRTX

WYNN

전 대통령 도널드 트럼프는 이전에 백악관에서 4년 동안 재직한 경험이 있기 때문에, 그가 2024년 대선에서 승리하여 두 번째 임기를 수행할 경우 어떤 주식과 섹터가 혜택을 볼 수 있을지 투자자들이 파악하는 데 도움이 될 수 있다.

트럼프 대통령 시기인 2017년 S&amp;P 500에서 가장 우수한 성과를 거둔 10개 주식: 역사가 반복될까?

Tesla Analysts Rave Over Cybercab's Design, Cost Advantage, But Production Timeline Sparks Worry

Movers

BEKE

FSLR

FUTU

NTES

미국에 상장된 중국 기업들의 주가는 약세로 인해 지난주 상승폭을 잃었다. 중국은 투자자들의 경기 부양 기대에 미치지 못해 2주 연속 상승세를 보인 후 하락세를 보인 것으로 알려졌다.

리 오토, 테슬라 및 니오는 지난주 최악의 성과를 보인 11개 대형주 중 일부 (10월 7일 - 10월 11일)

Align Technology Inc

Align Reports Commercial Availability Of Invisalign System With Mandibular Advancement Featuring Occlusal Blocks For Class II Skeletal And Dental Correction

Mizuho analyst Steven Valiquette maintains Align Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) with a Outperform and lowers the price target from $295 to $250.

Mizuho Maintains Outperform on Align Technology, Lowers Price Target to $250

The latest market downturn has left many investors questioning whether this is a temporary dip or the beginning of <a href="https://www.benzinga.com/markets">a prolonged bear market.</a>
Yet, an eye-opening indicator suggests that opportunities may be more abundant than feared—95% of S&amp;P 500 stocks currently hold a median analyst price target above their latest trading price, signaling significant upside potential across the board.
Notably, two Magnificent Seven stocks—Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)—rank among the top when comparing the gap between Wall Street&#8217;s median price target and current prices, a quite uncommon event for tech giants that traditionally trade at valuation premiums.
<h3 class="wp-block-heading">Is This A Market Bottom Or A Value Trap?</h3>
The S&amp;P 500 officially entered correction territory last week, leaving investors to wonder whether the worst is over or if further downside awaits.
Ed Yardeni, president of Yardeni Research, has been one of the more bullish voices on Wall Street. Last week, he raised his probability of a bearish scenario from 20% to 35%. That forecast includes the possibility of a recession or stagflation—a combination of stagnant growth and inflation.
Yardeni also acknowledged the possibility that a bear market may have begun on Feb. 20, the day after the S&amp;P 500 reached a record high. This shift in sentiment led him to lower his year-end 2025 S&amp;P 500 target from 7,000 to 6,400.
From a technical standpoint, only 41% of S&amp;P 500 stocks are trading above their 200-day moving average, signaling that most have fallen below a key trend support level, potentially confirming a bearish phase.
Yet, long-term market data provides a reason for optimism. 
Jeffrey Buchbinder, chief equity strategist at LPL Financial, points out that market corrections—defined as a decline of 10% or more—occur every 1.1 years on average, dating back to 1928. 
&#8220;Corrections also tend to produce attractive buying opportunities&#8221;
Since 1950, the S&amp;P 500 has experienced an average intra-year drawdown of a negative 13.7%, yet it has still managed to post an average annual gain of 9.5%, with 73% of those years ending in positive territory. 
Even in years when the index experienced an intra-year decline of 10% to 20%, the average annual return was still 8.4%, with 64% of those years finishing higher.
<h3 class="wp-block-heading">Which Stocks Have The Biggest Upside?</h3>
Based on current analyst price targets, several stocks stand out for their potential gains. 
Deckers Outdoor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) leads the list, with a median price target nearly 95% higher than its last price. First Solar Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) follows closely, with a projected upside of 93%.
Notably, Tesla and Nvidia, two of the most closely watched growth stocks, also rank high on the list. Analysts see Tesla's price target at $371.50, representing a 64.9% upside, while Nvidia's median price target sits at $175, implying a 51.6% gain from current levels.
Other stocks with significant upside potential include:
<ul>
<li>Caesars Entertainment Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>) &#8211; 81.4% potential upside</li>
<li>Western Digital Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) &#8211; 80.4% potential upside</li>
<li>United Airlines Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) &#8211; 80.2% potential upside</li>
<li>Delta Air Lines Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) &#8211; 72.0% potential upside</li>
</ul>
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>#</th>
<th>Stock name</th>
<th>Last Price</th>
<th>Price Target &#8211; Median</th>
<th>Target vs. Last Price %</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>Deckers Outdoor Corp.</td>
<td>115.30</td>
<td>225.00</td>
<td>95.14%</td>
</tr>
<tr>
<td>2</td>
<td>First Solar, Inc. </td>
<td>127.34</td>
<td>245.95</td>
<td>93.14%</td>
</tr>
<tr>
<td>3</td>
<td>Caesars Entertainment, Inc. </td>
<td>27.56</td>
<td>50.00</td>
<td>81.42%</td>
</tr>
<tr>
<td>4</td>
<td>Western Digital Corp.</td>
<td>44.34</td>
<td>80.00</td>
<td>80.42%</td>
</tr>
<tr>
<td>5</td>
<td>United Airlines Holdings, Inc. </td>
<td>71.34</td>
<td>128.60</td>
<td>80.26%</td>
</tr>
<tr>
<td>6</td>
<td>Delta Air Lines, Inc. </td>
<td>45.92</td>
<td>79.00</td>
<td>72.04%</td>
</tr>
<tr>
<td>7</td>
<td>Tesla, Inc. </td>
<td>225.31</td>
<td>371.50</td>
<td>64.88%</td>
</tr>
<tr>
<td>8</td>
<td>Norwegian Cruise Line Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>)</td>
<td>19.07</td>
<td>31.00</td>
<td>62.56%</td>
</tr>
<tr>
<td>9</td>
<td>Align Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>)</td>
<td>164.53</td>
<td>260.00</td>
<td>58.03%</td>
</tr>
<tr>
<td>10</td>
<td>Constellation Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>)</td>
<td>210.85</td>
<td>331.50</td>
<td>57.22%</td>
</tr>
<tr>
<td>11</td>
<td>MGM Resorts International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGM#NYSE">MGM</a>)</td>
<td>31.86</td>
<td>50.00</td>
<td>56.94%</td>
</tr>
<tr>
<td>12</td>
<td>Carnival Corp. &amp; plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>)</td>
<td>20.12</td>
<td>31.00</td>
<td>54.08%</td>
</tr>
<tr>
<td>13</td>
<td>Nvidia Corp. </td>
<td>115.43</td>
<td>175.00</td>
<td>51.61%</td>
</tr>
<tr>
<td>14</td>
<td>KKR &amp; Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>)</td>
<td>114.02</td>
<td>170.00</td>
<td>49.10%</td>
</tr>
<tr>
<td>15</td>
<td>Synchrony Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>)</td>
<td>53.05</td>
<td>79.00</td>
<td>48.92%</td>
</tr>
<tr>
<td>16</td>
<td>Iron Mountain Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRM#NYSE">IRM</a>)</td>
<td>87.62</td>
<td>127.50</td>
<td>45.51%</td>
</tr>
<tr>
<td>17</td>
<td>Royal Caribbean Cruises Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>)</td>
<td>203.38</td>
<td>295.00</td>
<td>45.05%</td>
</tr>
<tr>
<td>18</td>
<td>Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>)</td>
<td>96.44</td>
<td>139.00</td>
<td>44.13%</td>
</tr>
<tr>
<td>19</td>
<td>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>)</td>
<td>37.90</td>
<td>54.50</td>
<td>43.80%</td>
</tr>
<tr>
<td>20</td>
<td>Synopsys Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>)</td>
<td>447.99</td>
<td>644.00</td>
<td>43.75%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Data: Koyfin</figcaption></figure>
Read now: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44379453/equity-exposure-plummets-cash-holdings-jump-as-investors-rethink-us-exceptionalism-bank-of-america-survey">Equity Exposure Plummets, Cash Holdings Jump As Investors Rethink &#8216;US Exceptionalism,&#8217; Bank Of America Survey</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Equities

Large Cap

Mid Cap

Economics

DECK

DELL

NCLH

SMCI

SNPS

Analysts See Upside For 95% Of S&P 500 Stocks: How Nvidia, Tesla Stack Up

In the latest quarter, 7 analysts provided ratings for Align Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>), showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Align Technology and provided 12-month price targets. The average target is $261.71, accompanied by a high estimate of $280.00 and a low estimate of $235.00. Experiencing a 0.93% decline, the current average is now lower than the previous average price target of $264.17. 
<img src="https://www.benzinga.com/files/images/story/2025/1742331615_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A comprehensive examination of how financial experts perceive Align Technology is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jason Bednar</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$235.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Vik Chopra</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$255.00</td>
<td>-</td>
</tr>
<tr>
<td>Elizabeth Anderson</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$260.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Erin Wright</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$272.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Jason Bednar</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$270.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Brandon Couillard</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$260.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Michael Cherny</td>
<td>Leerink Partners</td>
<td>Raises</td>
<td>Outperform</td>
<td>$280.00</td>
<td>$235.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Align Technology. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Align Technology compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Align Technology's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Align Technology's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ALGN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Align Technology analyst ratings.</a>
<h2>About Align Technology</h2>
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
<h3>Key Indicators: Align Technology's Financial Health</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Align Technology's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 4.02%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Align Technology's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 10.43%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.66%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Align Technology's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.65% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.03.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 7 Analysts Discuss Align Technology Stock

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Goldman Sachs cut American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) price target from $367 to $330. Goldman Sachs analyst Ryan Nash maintained a Buy rating. American Express shares closed at $264.38 on Monday. See how other <a href="https://www.benzinga.com/quote/AXP/analyst-ratings">analysts view this stock.</a></li>
<li>Morgan Stanley slashed the price target for SentinelOne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) from $27 to $20. Morgan Stanley analyst Hamza Fodderwala maintained an Equal-Weight rating. SentinelOne shares closed at $18.91 on Monday. <a href="https://www.benzinga.com/quote/S/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stifel cut PENN Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>) price target from $22 to $19. Stifel analyst Steven Wieczynski maintained a Hold rating. PENN Entertainment shares closed at $17.26 on Monday. See how other analysts <a href="https://www.benzinga.com/quote/PENN/analyst-ratings">view this stock</a>.</li>
<li>RBC Capital cut the price target for GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) from $453 to $445. RBC Capital analyst Christopher Dendrinos maintained an Outperform rating. GE Vernova shares closed at $331.96 on Monday. <a href="https://www.benzinga.com/quote/GEV/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler cut the price target for Align Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) from $270 to $235. Piper Sandler analyst Jason Bednar reiterated an Overweight rating. Align Technology shares closed at $169.59 on Monday. <a href="https://www.benzinga.com/quote/ALGNX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Citigroup cut Seagate Technology Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) price target from $125 to $115. Citigroup analyst Asiya Merchant maintained a Buy rating. Seagate shares settled at $90.51 on Monday. <a href="https://www.benzinga.com/quote/STX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital cut Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) price target from $23 to $20. Loop Capital analyst Rob Sanderson maintained a Buy rating. Lyft shares closed at $12.03 on Monday. <a href="https://www.benzinga.com/quote/LYFT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Truist Securities slashed Incyte Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>) price target from $74 to $72. Truist Securities analyst Srikripa Devarakonda maintained a Hold rating. Incyte shares closed at $62.01 on Monday. &nbsp;<a href="https://www.benzinga.com/quote/INCY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>RBC Capital cut the price target for Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) from $440 to $320. RBC Capital analyst Tom Narayan maintained an Outperform rating. Tesla shares settled at $238.01 on Monday. <a href="https://www.benzinga.com/quote/TSLA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc slashed Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) price target from $220 to $202. Keybanc analyst Justin Patterson maintained an Overweight rating. Alphabet shares closed at $164.29 on Monday. <a href="https://www.benzinga.com/quote/GOOGL/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/03/44355158/jim-cramer-says-this-tech-stock-is-a-meme-stock-recommends-buying-accenture">Jim Cramer Calls This Stock A &#8216;Meme Stock,&#8217; Recommends Buying Accenture</a></li>
</ul>
Photo: Shutterstock

Tesla To $320? Here Are 10 Top Analyst Forecasts For Tuesday

WIIM

Align Technology shares are trading lower after Piper Sandler cut its price target on the stock from $270 to $235.

Piper Sandler analyst Jason Bednar reiterates Align Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) with a Overweight and lowers the price target from $270 to $235.

Reiteration

Piper Sandler Reiterates Overweight on Align Technology, Lowers Price Target to $235

Dentsply Sirona (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRAY#NASDAQ">XRAY</a>) and ZimVie Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZIMV#NASDAQ">ZIMV</a>) show below-market growth and have no meaningful upside, <a href="https://www.benzinga.com/general/health-care" target="_blank" rel="noreferrer noopener">according Needham analysts</a>.
What Happened: Needham downgraded the two dental companies to Hold.
ZimVie reported adjusted EPS of 27 cents, beating the consensus of 26 cents. The company&#8217;s sales of $111.52 million fell below the <a href="https://www.benzinga.com/pressreleases/25/02/g43989465/zimvie-reports-fourth-quarter-and-full-year-2024-financial-results" target="_blank" rel="noreferrer noopener">consensus of $113.4 million</a>.
Dentsply Sirona, meanwhile, reported fourth-quarter adjusted earnings per share of 26 cents. It missed the street view of 43 cents. Quarterly sales of $905 million (down 10.6% year over year) missed the analyst consensus estimate of $920.56 million. Organic Sales <a href="https://www.benzinga.com/news/earnings/25/02/44011524/dentsply-sirona-q4-earnings-miss-10-sales-drop-soft-2025-outlook-and-more" target="_blank" rel="noreferrer noopener">fell 10.7% year over year</a>.
In February, consumer sentiment in the U.S. declined. The University of Michigan&#8217;s Consumer Sentiment Index <a href="https://www.benzinga.com/general/market-summary/25/02/43889033/consumer-sentiment-drops-10-unitedhealth-under-investigation-whats-driving-markets-friday" target="_blank" rel="noreferrer noopener">dropped to 64.7 from 71.1</a> in January (initially reported as 73.2). Dental firms&#8217; management looks at consumer sentiment to gauge consumers&#8217; willingness to spend on dental care.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/02/44011524/dentsply-sirona-q4-earnings-miss-10-sales-drop-soft-2025-outlook-and-more" rel="noreferrer noopener">Dentsply Sirona Q4: Earnings Miss, 10% Sales Drop, Soft 2025 Outlook And More</a>
Why It Matters: Interest rates play a key role because major purchases are usually financed. While some rate cuts may start around midyear, high interest rates will likely continue to weigh on capital demand.
Adding to these challenges, ongoing staffing shortages in the provider market could limit capacity even if patient demand increases.
Analyst David Saxon writes that Dentsply Sirona continues to lose market share. The company is overexposed to equipment, he argues. That has been one of the softest product categories in dentistry, he adds. Low-cost/value launches from competitors have created pricing pressure, and interest rates remain a headwind to demand.
ZimVie is also losing implant market share — 60% of its portfolio. The company has upcoming initiatives meant to drive improved execution. The analyst expects it will take time for these to get ZimVie&#8217;s growth to be at or above the market&#8217;s growth.
Needham also comments on tariff exposure on another dental player, Align Technology, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>).
The clear aligners and iTero sleeves are covered under the USMCA (US-Mexico-Canada Agreement) and are exempt from tariffs until April 2025
Price Action: ALGN stock is down 3.59% at $158.66. XRAY stock is down 2.28% at $14.98. ZIMV stock is down 6.64% at $11.81 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44306214/gm-and-pge-team-up-to-let-evs-power-homes-offer-up-to-4500-in-energy-incentives" target="_blank" rel="noreferrer noopener">GM And PG&amp;E Team Up To Let EVs Power Homes, Offer Up To $4,500 In Energy Incentives</a></li>
</ul>

Downgrades

Health Care

General

XRAY

ZIMV

Dental Players Dentsply Sirona, ZimVie Show Weak Growth Outlook: Analyst

Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Wells Fargo analyst Vik Chopra initiated coverage on Henry Schein, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSIC#NASDAQ">HSIC</a>) with an Equal-Weight rating and announced a price target of $80. Henry Schein shares closed at $77.62 on Thursday. <a href="https://www.benzinga.com/quote/HSIC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Maxim Group analyst Michael Okunewitch initiated coverage on Mainz Biomed N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNZ#NASDAQ">MYNZ</a>) with a Buy rating and announced a price target of $14. Mainz Biomed shares closed at $6.53 on Thursday. <a href="https://www.benzinga.com/quote/MYNZ/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Benchmark analyst David Williams initiated coverage on Analog Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>) with a Buy rating and announced a price target of $245. Analog Devices shares closed at $209.34 on Thursday. <a href="https://www.benzinga.com/quote/ADI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Vik Chopra initiated coverage on Align Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) with an Overweight rating and announced a price target of $255. Align Tech shares closed at $204.89 on Thursday. <a href="https://www.benzinga.com/quote/ALGN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Lake Street analyst Jaeson Schmidt initiated coverage on BK Technologies Corporation (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BKTI#AMEX">BKTI</a>) with a Buy rating and announced a price target of $40. BK Technologies shares closed at $28.97 on Thursday. <a href="https://www.benzinga.com/quote/BKTI/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying ADI stock? Here&#8217;s what analysts think:
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="585" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14084410/image-2-43-1024x585.png" alt="" class="wp-image-783129" style="width:580px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14084410/image-2-43-1024x585.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14084410/image-2-43-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14084410/image-2-43-768x439.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14084410/image-2-43.png 1138w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43692962/top-3-consumer-stocks-you-may-want-to-dump-in-february">Top 3 Consumer Stocks You May Want To Dump In February</a></li>
</ul>

Initiation

Pre-Market Outlook

BKTI

CRSP

HSIC

MYNZ

This Analog Devices Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Analysts' ratings for Align Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) over the last quarter vary from bullish to bearish, as provided by 7 analysts.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Align Tech, revealing an average target of $257.57, a high estimate of $280.00, and a low estimate of $206.00. Marking an increase of 2.01%, the current average surpasses the previous average price target of $252.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1739538019_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Align Tech among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vik Chopra</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$255.00</td>
<td>-</td>
</tr>
<tr>
<td>Elizabeth Anderson</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$260.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Erin Wright</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$272.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Jason Bednar</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$270.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Brandon Couillard</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$260.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Michael Cherny</td>
<td>Leerink Partners</td>
<td>Raises</td>
<td>Outperform</td>
<td>$280.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>Michael Ryskin</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$206.00</td>
<td>$200.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Align Tech. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Align Tech compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Align Tech's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Align Tech's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ALGN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Align Tech analyst ratings.</a>
<h2>Delving into Align Tech's Background</h2>
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
<h3>Financial Insights: Align Tech</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Align Tech's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 1.84%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 11.86%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Align Tech's ROE stands out, surpassing industry averages. With an impressive ROE of 3.01%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Align Tech's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.85%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.03, Align Tech adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

7 Analysts Have This To Say About Align Tech

Wells Fargo analyst Vik Chopra initiates coverage on Align Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) with a Overweight rating and announces Price Target of $255.

Wells Fargo Initiates Coverage On Align Tech with Overweight Rating, Announces Price Target of $255

Deep-pocketed investors have adopted a bullish approach towards Align Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ALGN usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Align Tech. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 70% leaning bullish and 20% bearish. Among these notable options, 3 are puts, totaling $299,378, and 7 are calls, amounting to $354,454.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $185.0 to $250.0 for Align Tech during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Align Tech options trades today is 68.2 with a total volume of 465.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Align Tech's big money trades within a strike price range of $185.0 to $250.0 over the last 30 days.
<h3>Align Tech Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738867535_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ALGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$16.2</td>
<td>$15.3</td>
<td>$16.2</td>
<td>$210.00</td>
<td>$243.8K</td>
<td align="right">76</td>
<td align="right">150</td>
</tr>
<tr>
<td>ALGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$21.4</td>
<td>$21.3</td>
<td>$21.3</td>
<td>$220.00</td>
<td>$119.2K</td>
<td align="right">35</td>
<td align="right">62</td>
</tr>
<tr>
<td>ALGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$10.3</td>
<td>$10.1</td>
<td>$10.1</td>
<td>$250.00</td>
<td>$65.2K</td>
<td align="right">155</td>
<td align="right">78</td>
</tr>
<tr>
<td>ALGN</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$30.8</td>
<td>$20.8</td>
<td>$26.0</td>
<td>$210.00</td>
<td>$41.6K</td>
<td align="right">128</td>
<td align="right">16</td>
</tr>
<tr>
<td>ALGN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$30.5</td>
<td>$30.0</td>
<td>$30.0</td>
<td>$240.00</td>
<td>$39.0K</td>
<td align="right">23</td>
<td align="right">13</td>
</tr>
</tbody>
</table>

<h3>About Align Tech</h3>
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
<h3>Where Is Align Tech Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 1,428,416, the ALGN's price is up by 1.09%, now at $218.71. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 76 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Align Tech, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Behind the Scenes of Align Tech's Latest Options Trends

It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report <a href="https://www.benzinga.com/markets">set for Friday morning.</a>
The S&amp;P 500 and the Nasdaq 100 edged up 0.3%, while the Dow Jones slipped 0.1% and small caps held steady.
Among the leading sectors, financial stocks outperformed after the Fed released the framework for 2025 bank stress test. The big six banks — JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), Bank of America Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), Wells Fargo &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>), Goldman Sachs Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), and Citigroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) — all climbed more than 1%, with Citigroup surging 2.9%.
Eli Lilly Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) jumped 3.2% after topping earnings estimates, while Tapestry Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) surged 12% and Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) skyrocketed nearly 10% on strong revenue figures. In contrast, Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) slid 4.3% on concerns over slowing smartphone demand.
Shares of Palantir Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) surged 6.5%, extending its weekly gains to 30.8%, the stock's best weekly rally since early November.
Oil prices had a volatile session. Crude initially dipped as speculation mounted over a potential Trump-Putin meeting as early as this month or next, raising hopes for possible peace talks in Ukraine. Prices rebounded after the U.S. Treasury imposed sanctions on Iran's oil network.
Gold softened, dropping 0.6% from record highs and snapping a five-session winning streak.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) remained stable, hovering just below $97,000.
<h2 class="wp-block-heading">Thursday&#8217;s Performance In Major US Indices, ETFs</h2>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,742.18</td>
<td>0.4%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,082.15</td>
<td>0.3%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,316.14</td>
<td>0.0%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,811.50</td>
<td>-0.1%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 1:00 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020325&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;rose 0.3% to $605.83.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) eased 0.2% to $447.73.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;inched 0.3% up to $528.47.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) flattened at $229.55.</li>
<li>The&nbsp;Financial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>) outperformed, up 1.6%; the&nbsp;Energy Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 1.7%.</li>
</ul>
<h3 class="wp-block-heading">Thursday&#8217;s Stock Movers</h3>
Stocks reacting to corporate earnings, ordered by market capitalization, are:
<ul>
<li>Eli Lilly &amp; Co.: up 3.11%</li>
<li>Linde Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LIN#NYSE">LIN</a>): up 0.34%</li>
<li>Philip Morris International Inc.: up 9.97%</li>
<li>Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>): down 5.33%</li>
<li>ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>): down 0.71%</li>
<li>Hilton Worldwide Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>): up 4.65%</li>
<li>Bristol-Myers Squibb Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>): down 2.04%</li>
<li>Intercontinental Exchange Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>): up 4.95%</li>
<li>IQVIA Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>): up 2.95%</li>
<li>Yum! Brands Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>): up 8.49%</li>
<li>Hershey Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>): up 5.16%</li>
<li>McKesson Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCK#NYSE">MCK</a>): down 2.56%</li>
<li>Qualcomm Inc.: down 4.41%</li>
<li>Molina Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>): down 8.68%</li>
<li>O&#8217;Reilly Automotive Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>): down 1.87%</li>
<li>MetLife Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>): down 1.39%</li>
<li>Cognizant Technology Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSH#NASDAQ">CTSH</a>): up 3.64%</li>
<li>Corteva Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>): down 3.92%</li>
<li>Allstate Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>): down 0.07%</li>
<li>Skyworks Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>): down 23.74%</li>
<li>Aflac Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>): down 3.64%</li>
<li>Align Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>): down 0.66%</li>
<li>Equifax Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>): down 6.24%</li>
<li>Zimmer Biomet Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZBH#NYSE">ZBH</a>): down 3.02%</li>
<li>Aptiv Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>): up 4.18%</li>
<li>Air Products &amp; Chemicals Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>): down 1.75%</li>
<li>Kellanova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/K#NYSE">K</a>): up 0.12%</li>
<li>Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>): down 6.74%</li>
</ul>
Stocks reporting after the close include: 
<ul>
<li>Amazon.com Inc. </li>
<li>Illumina Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>)</li>
<li>Fortinet Inc.</li>
<li>Expedia Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>)</li>
<li>Take-Two Interactive Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>)</li>
<li>Monolithic Power Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>)</li>
<li>Pinterest Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>)</li>
<li>SS&amp;C Technologies Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>)</li>
<li>Principal Financial Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>)</li>
<li>Mettler-Toledo International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTD#NYSE">MTD</a>)</li>
<li>AptarGroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>)</li>
<li>Post Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/POST#NYSE">POST</a>)</li>
<li>Mohawk Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>)</li>
<li>Boyd Gaming Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYD#NYSE">BYD</a>)</li>
<li>Encompass Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHC#NYSE">EHC</a>)</li>
<li>VeriSign Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>)</li>
<li>Cloudflare Inc. </li>
<li>Skechers USA Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>)</li>
<li>Affirm Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>)</li>
<li>Elf Beauty Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>)</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43534297/january-jobs-report-preview-speculators-bet-on-strong-payroll-surge-yet-economists-predict-a-different-picture">January Jobs Report Preview: Speculators Bet On Strong Payroll Surge, Yet Economists Predict A Different Picture</a></li>
</ul>
Photo via Shutterstock.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Broad U.S. Equity ETFs

Commodities

Econ #s

ETFs

$BTC

AFRM

APTV

CTSH

CTVA

SPDR Dow Jones Industrial Average ETF Trust

EXPE

ILMN

MPWR

ORLY

PINS

PLTR

POST

QCOM

SSNC

SWKS

TTWO

VRSN

XLRE

Stocks Edge Higher, Bank Giants Rally, Palantir Skyrockets: What's Driving Markets Thursday?

Evercore ISI Group analyst Elizabeth Anderson maintains Align Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) with a Outperform and raises the price target from $240 to $260.

Evercore ISI Group Maintains Outperform on Align Tech, Raises Price Target to $260

Morgan Stanley analyst Erin Wright maintains Align Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) with a Overweight and lowers the price target from $280 to $272.

Morgan Stanley Maintains Overweight on Align Tech, Lowers Price Target to $272

Piper Sandler analyst Jason Bednar maintains Align Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) with a Overweight and lowers the price target from $275 to $270.

Piper Sandler Maintains Overweight on Align Tech, Lowers Price Target to $270

Needham analyst David Saxon reiterates Align Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) from Hold to Hold.

Needham Reiterates Hold on Align Techto Hold

Align Technology shares are trading lower after the company issued Q1 worldwide revenue guidance below estimates.

Guidance

Align Technology Sees Q1 Worldwide Revenue $965M-$985M vs $1.029B Est.; Sees Q1 Clear Aligner Volume Up Slightly Sequentially, Sees Q1 Clear Aligner ASPs Down Sequentially Due To Unfavorable Foreign Exchange And Product Mix Shift

Press Releases

Align Technology Announces Fourth Quarter and Fiscal 2024 Financial Results

Invisalign® Palatal Expander System by Align Technology Now Available in Turkey for Skeletal and Dental Expansion in Growing Patients

Align Technology Announces $225 Million Open Market Repurchase

HFD Announces it is now a Preferred Financing Partner of Align Technology to Offer Patient Financing for Invisalign® Treatment

Align Technology Announces Availability of Restorative Capabilities on Its Next Generation iTero Lumina™ Intraoral Scanner and New iTero Lumina™ Pro Dental Imaging System

Align Technology Launches Align X-ray Insights, an AI Computer-Aided Detection Software, in the European Union and United Kingdom

Align Technology's Invisalign® Brand Announces Official Sponsorship of Bay FC

Align Technology to Announce First Quarter 2025 Results on April 30, 2025

Align Technology Announces Invisalign® System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction

Align Technology to Host Investor Day on May 6, 2025

Advanced Biomed

Avanos Medical

Bioventus

Cerus

The Cooper Companies, Inc. - Common Stock

Cooper Companies

Cuprina Holdings (Cayman) Limited - Ordinary shares

Cuprina Holdings (Cayman)

Embecta

Establishment Labs Holdings Inc. - Common Shares

Establishment Labs Hldgs

Haemonetics

ICU Medical

OrthoPediatrics

Lantheus Holdings

Merit Medical Systems, Inc. - Common Stock

Merit Medical Systems

Neogen

InspireMD

OraSure Technologies, Inc. - Common Stock

OraSure Technologies

RxSight

Sanara MedTech

Solventum

Staar Surgical

UFP Technologies

Utah Medical Products, Inc. - Common Stock

Utah Medical Products

VolitionRX

Dentsply Sirona

Xtant Medical Holdings, Inc. Common Stock

Xtant Medical Hldgs

Mizuho

Piper Sandler

Wells Fargo

Evercore ISI Group

Morgan Stanley

화요일(18일) 월가의 상위 애널리스트들이 아래 종목에 대한 전망을 변경했다.  모든 애널리스트의 등급 변경 사항은 <a href="https://www.benzinga.com/analyst-stock-ratings" target="_blank" rel="noopener">애널리스트 등급 페이지</a>에서 확인할 수 있다.
<ul>
<li>골드만삭스는 아메리칸 익스프레스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) 목표주가를 367달러에서 330달러로 하향 조정했다. 골드만삭스 애널리스트 라이언 내쉬는 매수 등급을 유지했다. 아메리칸 익스프레스 주식은 월요일에 264.38달러로 마감했다. 다른 애널리스트들이 이 주식을 어떻게 평가하는지 보려면 <a href="https://www.benzinga.com/quote/AXP/analyst-ratings" target="_blank" rel="noopener">여기를 클릭하세요.</a></li>
<li>모건스탠리는 센티넬원(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) 목표주가를 27달러에서 20달러로 대폭 하향 조정했다. 모건스탠리 애널리스트 함자 포더왈라는 중립 등급을 유지했다. 센티넬원 주식은 월요일에 18.91달러로 마감했다. 다른 애널리스트들이 이 주식을 어떻게 평가하는지 보려면 <a href="https://www.benzinga.com/quote/S/analyst-ratings" target="_blank" rel="noopener">여기를 클릭하세요.</a></li>
<li>스티펠은 펜 엔터테인먼트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>) 목표주가를 22달러에서 19달러로 하향 조정했다. 스티펠 애널리스트 스티븐 비첸스키는 보유 등급을 유지했다. 펜 엔터테인먼트 주식은 월요일에 17.26달러로 마감했다. 다른 애널리스트들이 이 주식을 어떻게 평가하는지 보려면 <a href="https://www.benzinga.com/quote/PENN/analyst-ratings" target="_blank" rel="noopener">여기를 클릭하세요.</a></li>
<li>RBC 캐피털은 GE 버노바(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) 목표주가를 453달러에서 445달러로 하향 조정했다. RBC 캐피털 애널리스트 크리스토퍼 덴드리노스는 시장수익률 상회 등급을 유지했다. GE 버노바 주식은 월요일에 331.96달러로 마감했다. 다른 애널리스트들이 이 주식을 어떻게 평가하는지 보려면 <a href="https://www.benzinga.com/quote/GEV/analyst-ratings" target="_blank" rel="noopener">여기를 클릭하세요.</a></li>
<li>파이퍼 샌들러는 얼라인 테크놀로지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) 목표주가를 270달러에서 235달러로 하향 조정했다. 파이퍼 샌들러 애널리스트 제이슨 베드나르는 비중확대 등급을 재확인했다. 얼라인 테크놀로지 주식은 월요일에 169.59달러로 마감했다. 다른 애널리스트들이 이 주식을 어떻게 평가하는지 보려면 <a href="https://www.benzinga.com/quote/ALGNX/analyst-ratings" target="_blank" rel="noopener">여기를 클릭하세요.</a></li>
<li>씨티그룹은 씨게이트 테크놀로지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) 목표주가를 125달러에서 115달러로 하향 조정했다. 씨티그룹 애널리스트 아시아 머천트는 매수 등급을 유지했다. 씨게이트 주식은 월요일에 90.51달러로 마감했다. 다른 애널리스트들이 이 주식을 어떻게 평가하는지 보려면 <a href="https://www.benzinga.com/quote/STX/analyst-ratings" target="_blank" rel="noopener">여기를 클릭하세요.</a></li>
<li>루프 캐피털은 리프트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) 목표주가를 23달러에서 20달러로 하향 조정했다. 루프 캐피털 애널리스트 롭 샌더슨은 매수 등급을 유지했다. 리프트 주식은 월요일에 12.03달러로 마감했다. 다른 애널리스트들이 이 주식을 어떻게 평가하는지 보려면 <a href="https://www.benzinga.com/quote/LYFT/analyst-ratings" target="_blank" rel="noopener">여기를 클릭하세요.</a></li>
<li>트루이스트 증권은 인사이트 코퍼레이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>) 목표주가를 74달러에서 72달러로 하향 조정했다. 트루이스트 증권 애널리스트 스리크리파 데바라콘다는 보유 등급을 유지했다. 인사이트 주식은 월요일에 62.01달러로 마감했다. 다른 애널리스트들이 이 주식을 어떻게 평가하는지 보려면 <a href="https://www.benzinga.com/quote/INCY/analyst-ratings" target="_blank" rel="noopener">여기를 클릭하세요.</a></li>
<li>RBC 캐피털은 테슬라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) 목표주가를 440달러에서 320달러로 하향 조정했다. RBC 캐피털 애널리스트 톰 나라얀은 시장수익률 상회 등급을 유지했다. 테슬라 주식은 월요일에 238.01달러로 마감했다. 다른 애널리스트들이 이 주식을 어떻게 평가하는지 보려면 <a href="https://www.benzinga.com/quote/TSLA/analyst-ratings" target="_blank" rel="noopener">여기를 클릭하세요.</a></li>
<li>키뱅크는 알파벳(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) 목표주가를 220달러에서 202달러로 하향 조정했다. 키뱅크 애널리스트 저스틴 패터슨은 비중확대 등급을 유지했다. 알파벳 주식은 월요일에 164.29달러로 마감했다. 다른 애널리스트들이 이 주식을 어떻게 평가하는지 보려면 <a href="https://www.benzinga.com/quote/GOOGL/analyst-ratings" target="_blank" rel="noopener">여기를 클릭하세요.</a></li>
</ul>
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

전 대통령 도널드 트럼프는 이전에 백악관에서 4년 동안 재직한 경험이 있기 때문에, 그가 <a href="https://www.benzinga.com/topic/2024-election">2024년 대선</a>에서 승리하여 두 번째 임기를 수행할 경우 어떤 주식과 섹터가 혜택을 볼 수 있을지 투자자들이 파악하는 데 도움이 될 수 있다.
트럼프가 백악관에 처음 입성한 2017년에 가장 잘 수행된 주식들을 살펴보겠다.
2017년 최고의 주식들: 주식 시장은 2017년에 인상적인 상승세를 보였으며, 이는 대통령의 <a href="https://www.benzinga.com/markets/futures/18/01/11066769/the-stock-markets-rally-under-trump-among-the-best-ever-heres-how-his">첫 해에 가장 좋은 성과 중 하나</a>였다.
SPDR S&amp;P 500 ETF Trust(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)가 추적하는 S&amp;P 500은 2017년에 21.7% 상승했는데, 이는 2016년 +12.0% 상승에 비해 인상적인 상승률이다. 역사적으로 대통령 선거 연도가 다른 연도에 비해 뛰어난 성과를 거두었기 때문이다.
트럼프가 2024년에 재선될 가능성이 있는 만큼, 2017년 S&amp;P 500에서 가장 성과가 좋았던 10개 주식을 살펴보겠다. 이는 이전에 <a href="https://www.marketwatch.com/story/biggest-sp-500-winners-and-losers-of-2017-tech-health-care-and-home-builders-lead-2017-12-29">마켓워치</a>에 의해 보도된 내용다.
<ol>
<li>NRG 에너지 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>): +132%, 유틸리티</li>
<li>얼라인 테크놀로지 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>): +131%, 헬스케어</li>
<li>버텍스 파마슈티컬스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>): +103%, 헬스케어</li>
<li>윈 리조트 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>): +95%, 소비재</li>
<li>보잉 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>): +89%, 산업재</li>
<li>마이크론 테크놀로지 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>): +88%, 기술</li>
<li>D.R. 호튼 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>): +87%, 소비재, 주택 건설업체</li>
<li>페이팔 홀딩스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>): +87%, 기술</li>
<li>엔비디아 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>): +81%, 기술</li>
<li>풀테 그룹 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>): 81%, 소비재, 주택 건설업체</li>
</ol>
2017년의 상위 10개 주식들은 트럼프가 대통령인 것과 관련이 없는 이유로 상승세를 보였을 가능성이 있지만, 몇 가지 공통된 주제가 있으며 전 대통령과의 잠재적인 연결고리도 있다.
결과적으로 헬스케어, 소비재 및 기술 주식들이 상위 성과를 보이는 섹터로 나타났다.
특히 마이크론과 엔비디아가 모두 상위 10위 안에 든 점은 주목할 만한 사항으로, 이는 트럼프 대통령 하에서 반도체 섹터에 긍정적인 영향을 미칠 수 있다.
또한 두 개의 주택 건설사가 2017년 가장 성과가 좋았던 주식 중 두 개로 선정된 것은 중요한 추세일 수 있다. 주택 건설업체는 현재 부통령인 카멀라 해리스가 승리할 경우 주목할만한 섹터로 여겨져 왔으며, 트럼프는 중산층을 위한 <a href="https://www.benzinga.com/general/politics/24/08/40424431/harris-warns-trump-tax-plan-will-devastate-americans-vows-to-go-after-bad-actors-behind-food-pri">주택 건설 확대</a> 공약을 내세우고 있다.
알고 계셨나요?
<ul>
<li>의회가 막대한 투자를 하고 있습니다. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent102824">2024년 선거를 앞두고 그들이 매입하고 매각한 것에 대한 팁을 쉽게 알아보세요.</a></li>
</ul>
중요한 이유 (Why It&#8217;s Important): 과거의 결과가 미래의 결과를 보장하지는 않지만, 때때로 시장 추세는 패턴과 신호를 보여줄 수 있다.
2017년의 상위 성과 주식을 기반으로 볼 때, 트럼프가 2024년 대선에서 승리할 경우 투자자들은 헬스케어, 유틸리티, 반도체 및 주택 건설업체에 대한 <a href="https://www.benzinga.com/markets/equities/24/10/41213583/what-a-trump-win-could-mean-for-financial-energy-stocks-lessons-from-2016">노출을 준비</a>할 수 있다.
2024년 대선까지 2주도 채 남지 않았기 때문에, 투자자들은 트럼프나 해리스의 승리를 기준으로 포트폴리오를 조정하고 있을 가능성이 높다. 예측되는 근소한 선거 결과를 감안할 때, 투자자들은 두 후보 중 어느 쪽이 당선되더라도 혜택을 받을 수 있는 섹터를 살펴보는 것이 좋다.
프리덤 캐피털 마켓(Freedom Capital Markets)의 수석 글로벌 전략가 제이 우즈(Jay Woods)는 <a href="https://www.benzinga.com/etfs/sector-etfs/24/08/40515453/exclusive-trump-or-harris-12-stocks-2-etfs-could-win-no-matter-whos-president-says-market-strate">2024년 대선에서 트럼프나 해리스 승리 여부와 관계없이 주목해야 할 섹터와 주식</a>을 벤징가와 공유한 바 있다.
우즈는 방산 주식과 사이버 보안 주식을 2024년 대선 전 주목해야 할 두 개의 주요 섹터로 명명했다.
&#8220;이 섹터를 면밀히 주시해야 한다고 생각한다&#8221;라고 방산 섹터에 대해 우즈가 말했다.
우즈는 방산 주식이 지정학적 우려와 세계에서 발생하는 여러 문제들로 인해 계속해서 혜택을 받을 수 있다고 언급했다.
다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/general/sports-betting/24/10/41534317/if-trump-wins-2024-election-in-landslide-bettors-could-make-5x-20x-their-bets-at-uk-sports">트럼프가 2024년 대선에서 압승할 경우, 베팅자들은 영국 스포츠북에서 베팅금의 5배, 20배를 받을 수 있다.</a></li>
</ul>
사진: Shutterstock
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

트럼프 대통령 시기인 2017년 S&P 500에서 가장 우수한 성과를 거둔 10개 주식: 역사가 반복될까?

미국에 상장된 중국 기업들의 주가는 약세로 인해 지난주 상승폭을 잃었다. 중국은 투자자들의 경기 부양 기대에 미치지 못해 <a href="https://www.benzinga.com//node/41198527" target="_blank" rel="noreferrer noopener">2주 연속 상승세를 보인</a> 후 하락세를 보인 것으로 알려졌다.
지난주 가장 저조한 실적을 기록한 대형주 11개이다. 이들 주식이 귀하의 포트폴리오에 포함되어 있나요?
1. 넷이즈(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTES#NASDAQ">NTES</a>)의 주식은 13.66% 급락하여 상승세를 잃었다.
2. 후투 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>)의 주식은 중국의 부양책 조치에 대한 투자자들의 실망으로 13.25% 하락했다.
3. KE 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEKE#NYSE">BEKE</a>)의 주식이 13.14% 하락했다.
4. 테슬라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)의 주식은 사이버택시(Cybercab) 공개 이후 투자자들이 2026년 또는 2027년의 <a href="https://www.benzinga.com//node/41295072" target="_blank" rel="noreferrer noopener">가능성을 평가</a>하면서 12.91% 하락했다.
5. 토론토 도미니온 은행(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TD#NYSE">TD</a>)의 주식은 자금 세탁 방지 합의의 일환으로 회사가 약 30억 달러의 벌금을 지불하고 성장 제한에 직면할 것으로 예상된다는 <a href="https://www.benzinga.com//node/41271816" target="_blank" rel="noreferrer noopener">보도가 나온 후</a> 지난주 10.52% 하락했다.
6. 비스트라(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>)의 주식은 투자자들이 중국의 부양책 조치에 실망하면서 9.48% 하락했다.
7. 퍼스트 솔라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>)의 주식은 제프리스(Jefferies)가 목표 주가를 <a href="https://www.benzinga.com/quote/FSLR/analyst-ratings" target="_blank" rel="noreferrer noopener">271달러에서 266달러</a>로 하향 조정한 후 8.50% 하락했다.
8. AES 코퍼레이션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AES#NYSE">AES</a>)의 주식은 8.41% 하락했다.
9. 얼라인 테크놀로지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>)의 주식은 여러 애널리스트들이 <a href="https://www.benzinga.com/quote/algn/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 전망</a>을 하향 조정한 후 8.00% 하락했다.
10. 니오(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>)의 주식은 상승세를 잃고 7.83% 하락했다.
11. 리 오토(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>)의 주식은 상승세를 잃고 7.63% 하락했다.
또한 읽어보세요:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EC%9A%B0%EB%B2%84-%EB%B0%8F-%EB%A1%9C%EB%B9%88%ED%9B%84%EB%93%9C%EB%8A%94-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EA%B3%A0-%EC%84%B1%EA%B3%BC%EB%A5%BC-%EB%B3%B4%EC%97%AC%EC%A4%80-11%EA%B0%9C-%EB%8C%80/" target="_blank" rel="noopener">우버 및 로빈후드는 지난주 최고 성과를 보여준 11개 대형주 중 일부 (10월 7일-10월 11일)</a></li>
</ul>
사진 출처: Tesla
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

치과 교정에 사용되는 3D 디지털 스캐너와 인비절라인(Invisalign) 투명 교정 장치를 생산하는 미국 제조업체 얼라인 테크놀로지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>)의 주가는 회사가 2분기 재무 결과를 보고하고 <a href="https://www.benzinga.com/pressreleases/24/07/b39942047/align-technology-announces-second-quarter-2024-financial-results" target="_blank" rel="noopener" data-google-interstitial="false">약한 가이던스를</a> 발표한 후 수요일 시간외 세션에서 하락했다.
<ul>
<li>2분기 매출: 10.3억 달러로 예상치는 10.4억 달러</li>
</ul>
<ul>
<li>2분기 EPS: 2.41달러로 예상치는 2.30달러</li>
</ul>
총 매출은 약 1,160만 달러 또는 1.1%의 외환으로 인해 불리한 영향을 받은 후 전년 대비 2.6% 증가했다.
얼라인은 이번 분기 인비절라인 투명 교정 장치 매출이 전년 동기 대비 0.1% 감소한 8억 3,170만 달러를 기록했다고 밝혔다. 이미징 시스템 및 CAD/CAM 서비스 매출은 총 1억 9,680만 달러로 전년 대비 16.1% 증가했다.
&#8220;2분기에 십대 또는 더 어린 환자 케이스를 제출한 의사 수가 전년 대비 8% 증가했으며, 이는 &#8216;성장 환자&#8217;로 알려진 어린 아이들을 치료하는 의사들의 지속적인 강세에 힘입은 것이다. 2분기 실적은 또한 기록적인 수의 의사가 케이스를 제출했고, 분기 동안 기록적인 수의 의사에게 배송되었다&#8221;고 얼라인의 사장 겸 CEO인 조 호건(Joe Hogan)이 말했다.
6월 30일 현재 회사는 현금, 현금 등가물, 유가증권으로 7억 8,210만 달러를 보유하고 있으며 회전 신용 한도에 따라 사용 가능한 3억 달러를 보유하고 있다.
가이던스: <a href="http://pro.benzinga.com/" target="_blank" rel="noopener">Benzinga Pro</a>에 따르면 얼라인의 3분기 매출은 추정치 10억 3천만 달러 대비 9억 8천만 달러에서 10억 달러에 이를 것으로 예상된다. 얼라인은 2024년 전체 매출 성장을 4~6%로 예상하고 있다.
이 회사는 계절적 추세로 인해 3분기에 투명 교정 장치 볼륨이 감소할 것으로 예상한다고 밝혔다. 얼라인은 또한 3분기 계절성으로 인해 시스템 및 서비스 매출이 순차적으로 감소할 것으로 예상한다.
ALGN의 주가 움직임: 수요일 얼라인 주식은 4.00% 하락한 235.00달러에 거래되었다.
사진: Align 제공
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Earnings

After-Hours Center

얼라인 테크놀로지는 약한 2분기 매출 실적과 3분기 가이던스 발표 후 주가 하락

이들 10개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
<ol>
<li>게임스탑(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>)의 주가는 <a href="https://www.benzinga.com//node/39408371" target="_blank" rel="noopener" data-google-interstitial="false">연간 주주총회</a> 이후 지난주에 18.61% 하락했으며, CEO 라이언 코헨은 <a class="ticker" href="https://www.benzinga.com/news/24/06/39364816/why-are-gamestop-shares-moving-monday">비용 절감</a>을 통해 수익성을 향한 전략적 전환을 강조했다.</li>
<li>엔페이즈 에너지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>)의 주가는 JP모건이 주식에 대해 비중확대(Overweight) 의견을 유지했지만 <a href="https://www.benzinga.com//node/39413327" target="_blank" rel="noreferrer noopener">목표</a> 주가를 128달러에서 124달러로 낮추면서 17.60% 하락했다.</li>
<li>앨버말 코퍼레이션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>)의 <a href="https://www.benzinga.com//node/39336520" target="_blank" rel="noreferrer noopener">주식 가격은 11.53% 하락했다.</a></li>
<li>바이오엔텍 SE(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>)의 주가는 미 식품의약국(FDA)이 파트너인 메디링크 테라퓨틱스(Medilink Therapeutics)의 BNT326/YL202에 대한 임상 1상 시험에 대한 임상 <a href="https://www.benzinga.com//node/39362935">보류</a>를 결정한 후 지난주에 10.49% 하락했다.</li>
<li>얼라인 테크놀로지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>)의 주가는 파이퍼 샌들러(Piper Sandler)의 분석가가 <a class="ticker" href="https://www.benzinga.com/quote/ALGN/analyst-ratings">목표 주가를</a> 낮추면서 9.55% 하락했다.</li>
<li>퍼스트 솔라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLSR#NASDAQ">FLSR</a>)의 주식은 지난주 재니 몽고메리 스콧(Janney Montgomery Scott)이 주식의 평가를 매수에서 중립으로 <a href="https://www.benzinga.com/quote/FSLR/analyst-ratings">낮춘</a> 이후 8.87% 하락했다.</li>
<li>볼 코퍼레이션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BALL#NYSE">BALL</a>)의 주식 가격은 7.29% 하락했다. 웰스파고(Wells Fargo)의 애널리스트가 주식의 <a href="https://www.benzinga.com/quote/ball/analyst-ratings" target="_blank" rel="noreferrer noopener">목표 주가</a>를 낮췄다.</li>
<li>모빌아이 글로벌(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>)의 주식은 7.02% 하락했다.</li>
<li>탑빌더(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLD#NYSE">BLD</a>)의 주식은 6.97% 하락했다. 5월 주택 착공 및 건축 허가가 <a href="https://www.benzinga.com/real-estate/24/06/39412389/may-housing-market-blooms-inventory-and-listings-skyrocket" target="_blank" rel="noreferrer noopener">예상치를 하회하면서</a> 주택 건설업체, 건설 회사 및 주택 관련 주식의 가격이 하락했다.</li>
<li>자빌(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>)의 주식은 주가는 회사가 3분기 실적을 보고하고 <a href="https://www.benzinga.com//node/39432303" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">여러 분석가들이 전망을 하향 조정</a>한 후 5.56% 하락했다.</li>
</ol>
참고 자료: <a href="https://kr.benzinga.com/news/%eb%93%9c%eb%9e%98%ed%94%84%ed%8a%b8%ed%82%b9%ec%8a%a4%ec%99%80-%eb%8d%b8%ec%9d%80-%ec%a7%80%eb%82%9c%ec%a3%bc-%ec%b5%9c%ea%b3%a0%ec%9d%98-%ec%84%b1%ea%b3%bc%eb%a5%bc-%eb%b3%b4%ec%9d%b8-10%ea%b0%9c/" target="_blank" rel="noopener">드래프트킹스와 델은 지난주 최고의 성과를 보인 10개의 대형주 중 일부 (6월 16일-6월 22일)</a>

BALL

BNTX

ENPH

MBLY

RIVN

FLSR

게임스탑과 자빌은 지난주 최악의 성과를 보인 10개의 대형주 중 일부 (6월 16일-6월 22일)

Comments

Align Technology

뉴스

에 대한 최신 뉴스 Align Technology (NASDAQ:ALGN) 주식

수요일, 3월 19, 2025

월요일, 10월 28, 2024

월요일, 10월 14, 2024

목요일, 7월 25, 2024

일요일, 6월 23, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌